Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

17.0%

39 terminated/withdrawn out of 230 trials

Success Rate

76.2%

-10.3% vs industry average

Late-Stage Pipeline

21 trials in Phase 3/4

Results Transparency

61%

76 of 125 completed trials have results

Key Signals

32 recruiting76 with results22 terminated17 withdrawn

Enrollment Performance

Analytics

N/A

99(52.7%)

Phase 2

36(19.1%)

Phase 1

24(12.8%)

Phase 4

15(8.0%)

Early Phase 1

8(4.3%)

Phase 3

6(3.2%)

188Total

N/A(99)

Phase 2(36)

Phase 1(24)

Phase 4(15)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (230)

Showing 20 of 230 trials

NCT07560878Early Phase 1Recruiting

Synaptic Mechanisms of Continuous Theta Burst Stimulation in Depression

Role: lead

NCT07519759Not ApplicableNot Yet Recruiting

Recovery Inspired Support Engagement (RISE) Pilot

Role: lead

NCT07460947Phase 1Not Yet Recruiting

A Pilot Trial of One-Day Accelerated TMS and D-cycloserine in Suicidal Patients With Borderline Personality Disorder

Role: lead

NCT01517945Active Not Recruiting

Attention and Interpretation Modification (AIM) for Fear of Cancer Recurrence: An Intervention Development Study

Role: collaborator

NCT04697966Not ApplicableRecruiting

Mechanisms and Predictors of Change in App-Based Mindfulness Training for Adolescents

Role: lead

NCT06373016Not ApplicableRecruiting

Use of Ketosis in Modulating Metabolic Pathways in Bipolar Disorder

Role: collaborator

NCT06943404Phase 2Recruiting

BXCL501 After Stress to Increase Recovery Success

Role: collaborator

NCT06636786Phase 2Recruiting

Prevention/Reduction of ASRs and PTSD to Sustain Civilian Performance With Sublingual Cyclobenzaprine HCl (TNX-102 SL)

Role: collaborator

NCT04190563Not ApplicableCompleted

Pain, Inflammation and Opioid Craving

Role: lead

NCT05776966Not ApplicableCompleted

Women's Opioid Treatment Follow-up Study

Role: lead

NCT07503093Not ApplicableNot Yet Recruiting

Pilot Study of Sensor-Informed Smartphone-based Mental Health Interventions for Mood in Early Psychosis: A Micro-Randomized Trial

Role: lead

NCT07503067Recruiting

Identifying Substance Use Consequences

Role: lead

NCT06477406Phase 2Recruiting

Evaluating the Impact of a Novel Cannabinoid Product for Endometriosis

Role: lead

NCT04075435Early Phase 1Active Not Recruiting

Cannabidiol Solution for the Treatment of Behavioral Symptoms in Older Adults With Mild Cognitive Impairment or Alzheimer's Dementia

Role: lead

NCT05457465Phase 2Recruiting

Assessing the Impact of Cannabidiol for Anxiety and Depression in Bipolar Disorder

Role: lead

NCT04430517Early Phase 1Active Not Recruiting

Effects of Nicotinamide Riboside on Bioenergetics and Oxidative Stress in Mild Cognitive Impairment/Alzheimer's Dementia

Role: lead

NCT03484494Not ApplicableActive Not Recruiting

Low Field Magnetic Stimulation: Imaging Biomarkers in Geriatric Bipolar Depression

Role: lead

NCT06107764Not ApplicableRecruiting

Cerebellar Modulation of Cognition in Psychosis

Role: lead

NCT05753007Phase 2Terminated

A Clinical Trial of a Hemp-Derived, High Cannabidiol Product for Anxiety in Glioblastoma Patients

Role: lead

NCT01743716Completed

Genetic and Neural Predictors of Adolescent Depression

Role: lead